154 related articles for article (PubMed ID: 26821060)
1. pH-responsive PepFect cell-penetrating peptides.
Regberg J; Vasconcelos L; Madani F; Langel Ü; Hällbrink M
Int J Pharm; 2016 Mar; 501(1-2):32-8. PubMed ID: 26821060
[TBL] [Abstract][Full Text] [Related]
2. Rational design of a series of novel amphipathic cell-penetrating peptides.
Regberg J; Srimanee A; Erlandsson M; Sillard R; Dobchev DA; Karelson M; Langel U
Int J Pharm; 2014 Apr; 464(1-2):111-6. PubMed ID: 24463071
[TBL] [Abstract][Full Text] [Related]
3. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.
Lindberg S; Muñoz-Alarcón A; Helmfors H; Mosqueira D; Gyllborg D; Tudoran O; Langel U
Int J Pharm; 2013 Jan; 441(1-2):242-7. PubMed ID: 23200958
[TBL] [Abstract][Full Text] [Related]
4. Saturated Fatty Acid Analogues of Cell-Penetrating Peptide PepFect14: Role of Fatty Acid Modification in Complexation and Delivery of Splice-Correcting Oligonucleotides.
Lehto T; Vasconcelos L; Margus H; Figueroa R; Pooga M; Hällbrink M; Langel Ü
Bioconjug Chem; 2017 Mar; 28(3):782-792. PubMed ID: 28209057
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy.
Vasconcelos L; Lehto T; Madani F; Radoi V; Hällbrink M; Vukojević V; Langel Ü
Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):491-504. PubMed ID: 28962904
[TBL] [Abstract][Full Text] [Related]
6. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
7. Cell-penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids.
Juks C; Lorents A; Arukuusk P; Langel Ü; Pooga M
FASEB J; 2017 Mar; 31(3):975-988. PubMed ID: 27881484
[TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating peptides for siRNA delivery to glioblastomas.
Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
[TBL] [Abstract][Full Text] [Related]
9. Histidine-Rich Cell-Penetrating Peptide for Cancer Drug Delivery and Its Uptake Mechanism.
Zhang L; Xu J; Wang F; Ding Y; Wang T; Jin G; Martz M; Gui Z; Ouyang P; Chen P
Langmuir; 2019 Mar; 35(9):3513-3523. PubMed ID: 30673275
[TBL] [Abstract][Full Text] [Related]
10. PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation.
Ezzat K; Andaloussi SE; Zaghloul EM; Lehto T; Lindberg S; Moreno PM; Viola JR; Magdy T; Abdo R; Guterstam P; Sillard R; Hammond SM; Wood MJ; Arzumanov AA; Gait MJ; Smith CI; Hällbrink M; Langel Ü
Nucleic Acids Res; 2011 Jul; 39(12):5284-98. PubMed ID: 21345932
[TBL] [Abstract][Full Text] [Related]
11. Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides.
Vasconcelos L; Madani F; Arukuusk P; Pärnaste L; Gräslund A; Langel U
Biochim Biophys Acta; 2014 Dec; 1838(12):3118-29. PubMed ID: 25135660
[TBL] [Abstract][Full Text] [Related]
12. Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection.
Tan YX; Chen C; Wang YL; Lin S; Wang Y; Li SB; Jin XP; Gao HW; Du FS; Gong F; Ji SP
J Gene Med; 2012 Apr; 14(4):241-50. PubMed ID: 22328546
[TBL] [Abstract][Full Text] [Related]
13. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells.
Zhang W; Song J; Zhang B; Liu L; Wang K; Wang R
Bioconjug Chem; 2011 Jul; 22(7):1410-5. PubMed ID: 21663318
[TBL] [Abstract][Full Text] [Related]
14. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
15. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
[TBL] [Abstract][Full Text] [Related]
16. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
17. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
18. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
19. A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides.
Trabulo S; Resina S; Simões S; Lebleu B; Pedroso de Lima MC
J Control Release; 2010 Jul; 145(2):149-58. PubMed ID: 20362021
[TBL] [Abstract][Full Text] [Related]
20. Disruption of Tumor Cells Using a pH-Activated and Thermosensitive Antitumor Lipopeptide Containing a Leucine Zipper Structure.
Wang S; Wang T; Zhang J; Xu S; Liu H
Langmuir; 2018 Jul; 34(30):8818-8827. PubMed ID: 29914261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
